Content about DUBLIN

September 4, 2013

Cardinal Health announced that its board of directors has elected Patricia Hemingway Hall, president and CEO of Health Care Service Corp., as an independent director, effective Sept. 12.

DUBLIN, Ohio — Cardinal Health on Wednesday announced that its board of directors has elected Patricia Hemingway Hall, president and CEO of Health Care Service Corp., as an independent director, effective Sept. 12. 

September 3, 2013

With the window for Medicare enrollment opening on Oct. 15 and running through Dec. 7, Cardinal Health on Tuesday launched a customizable Medicare Enrollment Toolkit to help its retail pharmacy customers educate the rapidly growing Medicare-eligible population about coverage options.

DUBLIN, Ohio — With the window for Medicare enrollment opening on Oct. 15 and running through Dec. 7, Cardinal Health on Tuesday launched a customizable Medicare Enrollment Toolkit to help its retail pharmacy customers educate the rapidly growing Medicare-eligible population about coverage options. 

August 29, 2013

Cardinal Health on Tuesday announced that Tony Caprio, EVP in the Office of Customer Experience and general manager for the Healthcare IQ business partnership, will retire from the company after nearly 40 years of service to the healthcare community.

DUBLIN, Ohio — Cardinal Health on Tuesday announced that Tony Caprio, EVP in the Office of Customer Experience and general manager for the Healthcare IQ business partnership, will retire from the company after nearly 40 years of service to the healthcare community. Caprio will leave his current role at the end of December.

August 1, 2013

Cardinal Health is significantly bullish heading into fiscal 2014. And for good reason. Not only does the graying of the baby boomers continue to represent a strong tailwind, but there are five other factors that will help fill those sails as well, George Barrett, Cardinal chairman and CEO, told investors Thursday morning.

DUBLIN, Ohio — Cardinal Health is significantly bullish heading into fiscal 2014. And for good reason. Not only does the graying of the baby boomers continue to represent a strong tailwind, but there are five other factors that will help fill those sails as well, George Barrett, Cardinal chairman and CEO, told investors Thursday morning. 

July 10, 2013

Tria Beauty, a maker of laser and light-based skin care products, has announced the closing of $45.5 million in new equity financing and a new structured debt facility.

DUBLIN, Calif. — Tria Beauty, a maker of laser and light-based skin care products, has announced the closing of $45.5 million in new equity financing and a new structured debt facility. 

These funds will be used to launch multiple new laser devices for skin care, including the company's first device in the largest skincare segment — anti-aging. The funds will also allow the company to selectively expand distribution and accelerate its growth and operating plans, the company stated.

July 2, 2013

Covidien has finished spinning off its pharmaceuticals division, the medical products maker said.

DUBLIN — Covidien has finished spinning off its pharmaceuticals division, the medical products maker said.

St. Louis-based Covidien announced that it had separated Mallinckrodt as an independent company that has started trading on the New York Stock Exchange under the symbol "MNK," a move that it announced in December 2011. Shares in the newly public company were trading at $43.52 at noon Tuesday, down by 48 cents from the start of the day.

June 14, 2013

Irish drug maker Elan Corp. said Friday it was looking to sell itself off to a New York-based company that invests in drug royalties after rejecting a previous offer.

DUBLIN — Irish drug maker Elan Corp. said Friday it was looking to sell itself off to a New York-based company that invests in drug royalties after rejecting a previous offer.

The company said it would start a process to be acquired by Royalty Pharma, but that shareholders should not put their shares up for sale into another, hostile takeover attempt by Royalty, in which Royalty offered more than $7.7 billion, or $13 per share, plus $2.50 in milestone payments. Elan has rejected that offer, made last week.

May 29, 2013

Healthcare company Cardinal Health has released a series of studies showing ways that it says could reduce the cost of treating cancer.

DUBLIN, Ohio — Healthcare company Cardinal Health has released a series of studies showing ways that it says could reduce the cost of treating cancer.

May 23, 2013

Cardinal Health received the National Business Group on Health Platinum Best Employers for Healthy Lifestyles award for its ongoing commitment to promoting a healthy workplace and encouraging employees and their families to pursue and maintain healthy lifestyles.

DUBLIN, Ohio — Cardinal Health received the National Business Group on Health Platinum Best Employers for Healthy Lifestyles award for its ongoing commitment to promoting a healthy workplace and encouraging employees and their families to pursue and maintain healthy lifestyles.

May 22, 2013

Irish drug maker Elan is paying about $380 million to buy two drug makers, the company said.

DUBLIN — Irish drug maker Elan Corp. is paying about $380 million to buy one drug maker and a large stake in another, the company said.

Elan announced plans to buy Vienna-based AOP Orphan Pharmaceuticals for about $340 million, a company that specializes in drugs for rare conditions in a variety of areas, including cancer, neurology and metabolic disorders. Elan also paid an initial $40 million to buy a 48% stake in Newbridge Pharmaceuticals, based in Dubai, United Arab Emirates. Elan will have the option to buy the rest of the company for $244 million by 2015.

May 20, 2013

Actavis will acquire Warner Chilcott for $8.5 billion, the drug maker said.

PARSIPPANY, N.J. — Actavis will acquire Warner Chilcott for $8.5 billion, the drug maker said Monday.

May 14, 2013

A new infographic released Tuesday created by the Cardinal Health Foundation and The Ohio State University College of Pharmacy helps illustrate prescription drug abuse in the United States.

DUBLIN, Ohio — A new infographic released Tuesday created by the Cardinal Health Foundation and The Ohio State University College of Pharmacy helps illustrate prescription drug abuse in the United States.

Approximately 70% of people who abuse prescription medications get them from family or friends, often from medicine cabinets. On average, more than 10,000 people in the U.S. abuse prescription medications for the first time each day.

May 2, 2013

Cardinal Health reported fiscal year 2013 third-quarter revenue of $24.6 billion, a 8.9% decline as compared to the quarter a year ago.

DUBLIN, Ohio — Cardinal Health on Thursday reported fiscal year 2013 third-quarter revenue of $24.6 billion, a 8.9% decline as compared with the quarter a year ago. 

However, Cardinal Health reported net earnings per share of $1.01, up 5.2%. According to published reports, Wall Street had been expecting greater revenue of $24.7 billion but at a lesser gain with earnings expectations estimated around 96 cents per share. 

April 25, 2013

Cardinal Health and McKesson separately announced the renewal of their pharmaceutical distribution agreements with CVS Caremark.

DUBLIN, Ohio — Cardinal Health and McKesson separately announced the renewal of their pharmaceutical distribution agreements with CVS Caremark.

Under Cardinal Health’s renewed agreement, the wholesaler stated that it will supply pharmaceuticals to a network of CVS Caremark's retail pharmacies and distribution centers through mid-2016. The stores and distribution centers serviced under the new arrangement are essentially the same as those serviced in the prior arrangement.

April 23, 2013

Cardinal Health's philanthropic division is offering grants to organizations for programs to prevent abuse and misuse of prescription drugs.

DUBLIN, Ohio — Cardinal Health's philanthropic division is offering grants to organizations for programs to prevent abuse and misuse of prescription drugs.

The Cardinal Health Foundation said it was inviting non-profits in 18 locations around the country, as well as Puerto Rico, to apply for grant funding. The announcement marks the fourth year of the foundation's Prescription Drug Abuse and Misuse Prevention Grant Program.

April 23, 2013

The Food and Drug Administration has approved a new contraceptive drug made by Warner Chilcott, the drug maker said.

DUBLIN — The Food and Drug Administration has approved a new contraceptive drug made by Warner Chilcott, the drug maker said.

Warner Chilcott announced the approval of Minastrin 24 FE (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) for prevention of pregnancy.

The drug maker said an unnamed third-party company would manufacture the drug, but it did not expect to launch it this year.

 

April 17, 2013

Tria Beauty, a maker of light-based skin care products and technology, has inked a new partnership with beauty retailer Ulta.

DUBLIN, Calif. — Tria Beauty, a maker of light-based skin care products and technology, has inked a new partnership with beauty retailer Ulta.

Ulta will be featuring the Tria Hair Removal Laser 4X, the Tria Skin Perfecting Blue Light for acne and a line of topical skin care products on Ulta.com. The Tria Laser 4X and SmoothStart Calming Gel will launch in 25 Ulta doors in mid-April.

April 16, 2013

The Food and Drug Administration has approved a new strength of an antibiotic made by Warner Chilcott, the drug maker said.

DUBLIN — The Food and Drug Administration has approved a new strength of an antibiotic made by Warner Chilcott, the drug maker said.

Warner Chilcott announced the approval of the 200-mg strength of Doryx (doxycycline hyalite) delayed-release tablets, which the company plans to release in July 2013.

Doryx delayed-release tablets are already available in the 75-mg, 100-mg and 150-mg strengths.

 

April 15, 2013

HealthSpot, a provider of telehealth technology, has been asked to present at the Consumer Electronics Association 2013 CES on the Hill, the company has announced.

DUBLIN, Ohio — HealthSpot, a provider of telehealth technology, has been asked to present at the Consumer Electronics Association 2013 CES on the Hill, the company has announced.

April 10, 2013

With the growing concern of the abuse of prescription stimulants like Adderall on college campuses, the Cardinal Health Foundation and the Ohio State University College of Pharmacy introduced Generation Rx University, the fourth in a series of interactive toolkits designed to help reduce the abuse of prescription drugs.

DUBLIN, Ohio — With the growing concern of the abuse of prescription stimulants like Adderall on college campuses, the Cardinal Health Foundation and the Ohio State University College of Pharmacy on Wednesday introduced Generation Rx University, the fourth in a series of interactive toolkits designed to help reduce the abuse of prescription drugs. 

March 19, 2013

In the wake of a new partnership announcement between Walgreens and AmerisourceBergen, Cardinal Health announced on that its pharmaceutical distribution contract with Walgreens that is scheduled to expire at the end of August 2013 will not be renewed.

DUBLIN, Ohio — In the wake of a new partnership announcement between Walgreens and AmerisourceBergen, Cardinal Health announced on Tuesday that its pharmaceutical distribution contract with Walgreens that is scheduled to expire at the end of August 2013 will not be renewed.

March 13, 2013

Sephora is previewing the newest innovation of the Tria Hair Removal Laser for acne and the company's line of topical skin care products on Sephora.com.

 DUBLIN, Calif. — Tria Beauty has announced a new partnership with beauty retailer Sephora.

Sephora is previewing the newest innovation of the Tria Hair Removal Laser for acne and the company's line of topical skin care products on Sephora.com. The Tria Hair Removal Laser 4X and SmoothStart Calming Gel will launch in select U.S. stores.

February 14, 2013

Cardinal Health announced plans to acquire privately held AssuraMed, a provider of medical supplies to patients in the home, for $2.1 billion.

DUBLIN, Ohio — Cardinal Health on Thursday announced plans to acquire privately held AssuraMed, a provider of medical supplies to patients in the home, for $2.1 billion. 

February 8, 2013

Elan will sell the rights to its drug for multiple sclerosis to partnering company Biogen Idec for $3.25 billion plus royalties, the Irish drug maker said.

DUBLIN - Elan Corp. will sell the rights to its drug for multiple sclerosis to partnering company Biogen Idec for $3.25 billion plus royalties, the Irish drug maker said.

February 8, 2013

The Food and Drug Administration has approved a new drug from Warner Chilcott for treating ulcerative colitis, the drug maker said.

DUBLIN — The Food and Drug Administration has approved a new drug from Warner Chilcott for treating ulcerative colitis, the drug maker said.

Warner Chilcott announced the approval of mesalamine in the 400-mg strength.

The company plans to market the drug under the brand name Delzicol and launch it in March.